Skip to content

Cohort study, 2025

How do menstrual cycle phase and birth control type affect sleep and training readiness?

All female endurance athletes reported higher symptom severity during bleeding days and lower sleep quality and training readiness before menstruation, with some differences by birth control type. These patterns held for both pill and non-pill users.

Moderate study design 58 female endurance athletes

What they did

58 female endurance athletes were followed for 1 year. They recorded daily measurements of sleep quality, readiness to train, resting heart rate, symptom severity, and menstrual or withdrawal bleeding days. Athletes were grouped by contraceptive type: intrauterine system, implant, progestin-only pill, combined pill, or none.

What they found

All groups reported higher symptom severity during bleeding compared to non-bleeding days. Women using combined birth control pills reported lower sleep quality before bleeding and lower training readiness compared to women not using contraception. Symptom severity was linked to worse sleep and lower training readiness across all groups.

What it means for you

Pre-menstrual and menstrual phases reduce sleep quality and readiness to exercise in female endurance athletes, with those on certain birth control pills showing slightly larger effects. Athletes should adjust recovery strategies based on their cycle phase. The study has no direct control group for comparison.

58

athletes followed

1

year of tracking

5

contraceptive groups compared

About the study

Original title
Influence of menstrual- and hormonal contraceptive cycle on self-reported symptom severity and recovery measures across an annual season in female endurance athletes: The FENDURA project
Authors
Engseth TP, Osborne JO, Solli GS et al.
Journal
Journal of sports sciences
Year
2025
Study design
Cohort study
What was tested
Tracking of recovery and symptoms across menstrual cycle phases
Open access
Yes
Original abstract

This longitudinal study investigated 1) differences in self-reported cycle-related symptom severity and recovery measures (sleep quality, readiness to train, resting heart rate) between pre-bleeding, bleeding, and non-bleeding days in athletes using/not using hormonal contraception (HC); 2) associations between symptom severity and recovery measures. Fifty-eight female endurance athletes recorded recovery measures, perceived symptom severity, and menstruation/withdrawal (bleeding) days for one year. Athletes were grouped as: intrauterine system (IUS)-, implant-, progestin-only oral contraceptive (POC)-, combined oral contraceptive (COC)- and non-HC users. All groups reported higher symptom severity during bleeding compared to pre-bleeding and non-bleeding days (both p p p = .008). Perceived sleep quality was lower during pre-bleeding compared to bleeding days ( p p = .039) and physical readiness-to-train ( p = .010) than non-HC users. Symptom severity was negatively associated with sleep quality and physical readiness-to-train (both p < .050). Pre-bleeding days and cycle-related symptom severity were found to negatively influence self-reported recovery measures in both HC- and non-HC users. Therefore, athletes and their support staff are advised to prioritize symptom management and the adjustment of recovery strategies on an individual basis throughout the athletes' cycles.

Reproduced under CC-BY.

Topics